Business Description
Enzolytics Inc
NAICS : 325412
SIC : 2834
2000 North Central Expressway, Plano, TX, USA, 75074
Compare
Compare
Traded in other countries / regions
ENZC.USA
Description
Enzolytics Inc is a biotechnology company, whose products consist of multiple distinct drug development proprietary technologies: Immunotherapy, immune modulators, fully human monoclonal antibodies and an artificial intelligence (AI) platform for heath care developments. The Company has clinically tested anti HIV therapeutics. Additionally, the Company has created a proprietary cell line that produces fully human monoclonal antibodies that target and neutralizes the HIV virus.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Piotroski F-Score | 0/9 | |||||
Altman Z-Score | 0 | |||||
Beneish M-Score | 0 |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 26.68 | |||||
9-Day RSI | 32.42 | |||||
14-Day RSI | 36.65 | |||||
6-1 Month Momentum % | -34.36 | |||||
12-1 Month Momentum % | -58.44 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History |
---|
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
Name | Current | Vs Industry | Vs History |
---|
GF Value Rank
Name | Current | Vs Industry | Vs History |
---|
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Gurus Latest Trades with OTCPK:ENZC
Executives
EMBED
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 0.046 | ||
EPS (TTM) ($) | -170.268 | ||
Beta | 0.87 | ||
Volatility % | 83.23 | ||
14-Day RSI | 36.65 | ||
14-Day ATR ($) | 0.004123 | ||
20-Day SMA ($) | 0.058571 | ||
12-1 Month Momentum % | -58.44 | ||
52-Week Range ($) | 0.0532 - 0.2075 | ||
Shares Outstanding (Mil) | 2,438.67 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 0 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Enzolytics Inc Filings
Document | Form | Filing Date | ||
---|---|---|---|---|
No Filing Data |